S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00054054
Recruitment Status : Completed
First Posted : February 6, 2003
Last Update Posted : July 25, 2011
National Cancer Institute (NCI)
Information provided by:
Southwest Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2007
  Study Completion Date : No date given
Publications of Results:
Adelstein DJ, Moon J, Hanna E, et al.: S0216: a Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC). [Abstract] J Clin Oncol 25 (Suppl 18): A-6014, 302s, 2007.